ArticleThe Journal of biological chemistry2026
Mapping the multi-domain allosteric network for CKAMP44 modulation of AMPA receptors.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most fast excitatory neurotransmission is mediated by AMPA-type ionotropic glutamate receptors, whose gating properties are fine-tuned by a wide range of auxiliary subunits. While bulky, multi-pass auxiliary subunits such as transmembrane AMPAR regulatory proteins (TARPs) and cornichons (CNIHs) dominate current structural models of receptor regulation by forming a stabilizing girdle around the ligand-binding and transmembrane domains, the modulatory mechanisms of simpler, single-pass transmembrane proteins like cysteine-knot AMPA receptor-modulating protein 44 (CKAMP44), also known as Shisa9, remain a critical missing link in understanding allosteric control. To identify the molecular drivers of CKAMP44 regulation, we utilized our previously characterized library of reciprocal chimeric receptors containing swapped domains between the CKAMP44-sensitive AMPAR subunit GluA2 and the CKAMP44-insensitive kainate receptor GluK2. Using whole-cell patch-clamp electrophysiology, we demonstrate that CKAMP44 modulation is not localized to a single interface but relies on a distributed allosteric network. The findings indicate a novel and essential role for the receptor's amino-terminal domain (ATD) in facilitating the CKAMP44-mediated enhancement of desensitization entry, thereby pinpointing a new site for gating regulation. Furthermore, we find that CKAMP44 functionally rescues previously non-conductive transmembrane-carboxy-terminal chimeras, highlighting a critical role in stabilizing compromised receptor assemblies. Conversely, the modulation of receptor's recovery from desensitization appears mechanistically distinct, governed primarily by the stability of the ligand-binding domain and transmembrane (TMD) interface. We propose a hierarchical dual-action model of allosteric regulation wherein the canonical gating machinery of the ligand-binding and transmembrane domains cassette is distinctly fine-tuned by distal interactions at the ATD, establishing a newly identified regulatory layer for auxiliary subunit engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.